STOP T1D

02/20/2026

Health Care Providers: Why screen for pre-symptomatic type 1 diabetes? We have 5 good reasons to share with you from the Barbara Davis Center for Diabetes' Ask the Experts and STOP T1D programs.

Learn more:
AskTheExperts.org/for-providers
STOPT1Dprogram.org/for-HCP
BarbaraDavisCenter.org

02/18/2026

Know the signs and symptoms of type 1 diabetes!

See the accompanying graphic for the most common T1D symptoms.

To learn more, visit BarbaraDavisCenter.org and STOPT1Dprogram.org.

For no cost and disease screening information, visit ASKhealth.org

02/16/2026

⭐️ Health Care Providers and Medical Researchers!

Join us tomorrow, Tuesday, February 17 at 9 AM PST Noon EST for T1D Monitoring-Challenges for Implementation and Engagement

Hosted by The Sugar Science, our panelists include:
🔹 Brigitte Frohnert MD, PhD — University of Colorado, Anschutz
🔹 Kurt Griffin MD, PhD — Benaroya Research Institute
🔹 Kimber Simmons MD, MS — University of Colorado, Anshcutz
🔹 Jennifer Law MD, MSCR — University of North Carolina

AGENDA includes:
• Goals of monitoring: Prevent DKA; intervention; immunologic phenotyping (TCR phenotypes)
• Strategies for monitoring: A1c, OGTT, CGM
• PLEDGE monitoring overview
• ASK monitoring overview
• Early Check monitoring overview
• Q&A Session

Register: https://us02web.zoom.us/meeting/register/nq5ExonlTR-S5qIbqD6wOg

02/13/2026

🔔 EVENT REMINDER - Wednesday, February 18: Health Care Providers - This upcoming "Ask the Experts" Office Hours is an interactive 1-hr Zoom call to discuss early questions and cases.

Hosted by the Ask the Experts Team at the Barbara Davis Center for Diabetes

Mark your calendar to attend: Wednesday, February 18, 2026 | NOON – 1:00 PM (MST)

Participants may earn 1 credit for attending this session.

Register to attend: Office Hours | Ask the Experts >

Registration Form for our monthly "Office Hours" Zoom call for HCPs — to discuss early T1D questions and cases.

02/12/2026

The Barbara Davis Center for Diabetes' (BDC) research goals include investigation of the causes of type 1 diabetes, the early detection of autoimmunity, prevention and early intervention. In addition, BDC is developing new treatments, including a focus on the artificial pancreas, and prevention strategies for complications of both type 1 and type 2 diabetes, and the outcomes of care of type 1 diabetes.

Learn more about our research: https://medschool.cuanschutz.edu/barbara-davis-center-for-diabetes/research

STOPT1Dprogram.org is a BDC program providing education and resource information for Health Care Providers ( ) by offering meaningful Continuing Medical Education ( ) on the importance of screenings, diagnoses, and patient monitoring.

02/11/2026

In their review of emerging research and technologies, Diabettech gets to the key point: "As of February 5, 2026, the signal cutting through the noise has shifted from hardware on the skin to the deep cellular architecture of the body. From 'immune niches' that act as early-warning systems to cell therapies that refuse to quit after seven years, the frontier of diabetes care is officially moving inside."

The Daily Bolus: Early Warnings, Genetic Cloaks, and the Seven-Year Shield | Diabettech - Diabetes and Technology https://www.diabettech.com/the-daily-bolus-early-warnings-genetic-cloaks-and-the-seven-year-shield/

Whilst the title of this edition sounds like something out of science fiction, in it we see a masterclass in "biological intelligence." As of February 5, 2026, the signal cutting through the noise has shifted from hardware on the skin to the deep cellular architecture of the body. From "immune niche...

02/10/2026

Learn the 3 stages of how type 1 diabetes progresses from detection to treatment phases.

We encourage everyone to get screened for before symptoms appear, especially since too often those symptoms may be ignored, putting a person at significant health risk. FREE screenings are available. Visit our screening program website at ASKhealth.org

Visit STOPT1Dprogram.org to access important resources - including a free course covering T1D screening, diagnoses, and monitoring created especially for health care providers by the Barbara Davis Center for Diabetes (BarbaraDavisCenter.org).

02/09/2026

Health Care Providers and Scientific Researchers! This educational event taking place tomorrow online is for YOU!

✅ Please join type 1 diabetes physician researchers, including three Barbara Davis Center faculty, in collaboration with The Sugar Science, on an expert T1D panel taking place this Tuesday, February 10, 2026 at 9 AM PT/ noon ET.

T1D Screening- Moving from research to clinical implementation

Panelists:
Brigitte Frohnert MD, PhD-University of Colorado - Anschutz
Marian Rewers MD, PhD - University of Colorado - Anschutz
Jennifer Law MD, MSCR - University of North Carolina
Kurt Griffin MD PhD - Benaroya Research Institute
Kimber Simmons MD MS- University of Colorado, Anshcutz

Presentation:
Brigitte Frohnert- Summary of epidemiology
Marian Rewers- ASK program outline
Kurt Griffin- PLEDGE program outline
Jennifer Law- Early Check program outline

Questions and Answer Session

Register for T1D screening- Moving from Research to Clinical Implementation: https://us02web.zoom.us/meeting/register/ztPqM57KROGrYlB87aYv2w #/registration

02/06/2026

New in ...

"Ketoacidosis at childhood type 1 diabetes onset negatively affects residual beta-cell functions during the first year after diagnosis " Nature | Scientific Reports https://www.nature.com/articles/s41598-026-38533-4

"Our results showed that DKA at T1D negatively affects residual beta-cell function during the year after diagnosis."

This study investigates whether pediatric patients presenting with diabetic ketoacidosis (DKA) at the time of type 1 diabetes (T1D) diagnosis experience increased insulin requirements, reduced rates of partial remission, and diminished C-peptide secretion over the first year post-diagnosis, relative...

02/05/2026

This is welcome news! The Special Diabetes Program ( ) passes in Congress to fund research through 2026.

"A recent study conducted by Avalere Health shows that of the nearly 3.6 billion invested into the SDP by Congress since the establishment of the program, the Federal Government has realized $50 billion in healthcare savings through improved health outcomes from the use of SDP driven therapies and devices. This demonstrates a strong return on investment for both patients and taxpayers"

"Congress passes bipartisan extension of the Special Diabetes Program, securing critical T1D research funding" - Breakthrough T1D https://www.breakthrought1d.org/news-and-updates/congress-passes-bipartisan-extension-of-the-special-diabetes-program-securing-critical-t1d-research-funding/

Congress passed bipartisan legislation to extend and strengthen the Special Diabetes Program, a cornerstone of Federal investment in type 1 diabetes research.

02/04/2026

Why Early Detection of T1D Matters to Physicians: Understanding the Impact on Patient Lives.

(T1D) can happen to anyone, no matter their age, overall health, weight, or how fit they are. Even though having a family member with T1D makes a person 15X more likely to get T1D, over 90% of people diagnosed each year don't have anyone in their family with T1D. Screening for related autoantibodies can identify if a patient is likely to develop T1D long before they show symptoms.

STOP T1D is an continuing medical education ( ) program for US health care providers to learn about T1D screening, diagnosis, and monitoring protocols.

Learn more at STOPT1Dprogram.org/for-hcp

02/03/2026

Office Hours | Ask the Experts

Registration Form for our monthly "Office Hours" Zoom call for HCPs — to discuss early T1D questions and cases.